Detalles de la búsqueda
1.
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.
Blood
; 140(10): 1167-1181, 2022 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35853161
2.
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.
Br J Haematol
; 203(2): 264-281, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37539479
3.
Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling.
Cell Commun Signal
; 17(1): 5, 2019 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30651113
4.
NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells.
Cell Commun Signal
; 12: 75, 2014 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25477292
5.
Constitutive Akt1 signals attenuate B-cell receptor signaling and proliferation, but enhance B-cell migration and effector function.
Eur J Immunol
; 42(12): 3381-93, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22930469
6.
Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells.
Biomed Pharmacother
; 168: 115635, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37816303
7.
Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness.
Oncotarget
; 7(33): 53797-53807, 2016 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27462773
8.
Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.
Mol Cell Biol
; 34(5): 820-31, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24344200
Resultados
1 -
8
de 8
1
Próxima >
>>